Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $33
Benzinga Newsdesk 21 hours ago
Analyst RatingsNewsPrice Target
Canaccord Genuity analyst William Plovanic maintains CeriBell (NASDAQ:CBLL) with a Buy and raises the price target from $26 to $33.
Canaccord Genuity analyst William Plovanic maintains CeriBell (NASDAQ:CBLL) with a Buy and raises the price target from $26 to $33.